2.4.0.8 HtmlAndXml 101 215 1 false 41 0 false 4 false false R1.htm 101 - Document - Document and Entity Information Sheet http://www.opexatherapeutics.com/taxonomy/role/DocumentDocumentandEntityInformation Document and Entity Information R1.xml true false R2.htm 103 - Statement - Consolidated Balance Sheets Sheet http://www.opexatherapeutics.com/taxonomy/role/StatementOfFinancialPositionClassified Consolidated Balance Sheets R2.xml false false R3.htm 104 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.opexatherapeutics.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical Consolidated Balance Sheets (Parenthetical) R3.xml false false R4.htm 105 - Statement - Consolidated Statements of Operations Sheet http://www.opexatherapeutics.com/taxonomy/role/StatementOfIncomeAlternative Consolidated Statements of Operations R4.xml false false R5.htm 106 - Statement - Consolidated Statements of Changes In Stockholders' Equity Sheet http://www.opexatherapeutics.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncome Consolidated Statements of Changes In Stockholders' Equity R5.xml false false R6.htm 107 - Statement - Consolidated Statements of Changes In Stockholders' Equity (Parenthetical) Sheet http://www.opexatherapeutics.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncomeParenthetical Consolidated Statements of Changes In Stockholders' Equity (Parenthetical) R6.xml false false R7.htm 108 - Statement - Consolidated Statements of Cash Flows Sheet http://www.opexatherapeutics.com/taxonomy/role/StatementOfCashFlowsIndirect Consolidated Statements of Cash Flows R7.xml false false R8.htm 109 - Disclosure - Basis of Presentation Sheet http://www.opexatherapeutics.com/taxonomy/role/NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock Basis of Presentation R8.xml false false R9.htm 110 - Disclosure - Significant Accounting Polices Sheet http://www.opexatherapeutics.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock Significant Accounting Polices R9.xml false false R10.htm 111 - Disclosure - Other Current Assets Sheet http://www.opexatherapeutics.com/taxonomy/role/NotesToFinancialStatementsOtherCurrentAssetsTextBlock Other Current Assets R10.xml false false R11.htm 112 - Disclosure - Restricted Cash Sheet http://www.opexatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfRestrictedCashAndCashEquivalentsTextBlock Restricted Cash R11.xml false false R12.htm 113 - Disclosure - Deferred Financing Costs Sheet http://www.opexatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDeferredChargesDisclosureTextBlock Deferred Financing Costs R12.xml false false R13.htm 114 - Disclosure - Other Assets Sheet http://www.opexatherapeutics.com/taxonomy/role/NotesToFinancialStatementsOtherAssetsNoncurrentDisclosureTextBlock Other Assets R13.xml false false R14.htm 115 - Disclosure - Convertible Promissory Notes Notes http://www.opexatherapeutics.com/taxonomy/role/NotesToFinancialStatementsLongTermDebtTextBlock Convertible Promissory Notes R14.xml false false R15.htm 116 - Disclosure - Related Party Transactions Sheet http://www.opexatherapeutics.com/taxonomy/role/NotesToFinancialStatementsRelatedPartyTransactionsDisclosureTextBlock Related Party Transactions R15.xml false false R16.htm 117 - Disclosure - Equity Sheet http://www.opexatherapeutics.com/taxonomy/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlock Equity R16.xml false false R17.htm 118 - Disclosure - Stock-Based Compensation Sheet http://www.opexatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock Stock-Based Compensation R17.xml false false R18.htm 119 - Disclosure - Subsequent Events Sheet http://www.opexatherapeutics.com/taxonomy/role/NotesToFinancialStatementsSubsequentEventsTextBlock Subsequent Events R18.xml false false R19.htm 120 - Disclosure - Significant Accounting Polices (Policies) Sheet http://www.opexatherapeutics.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockPolicies Significant Accounting Polices (Policies) R19.xml false false R20.htm 121 - Disclosure - Other Current Assets (Tables) Sheet http://www.opexatherapeutics.com/taxonomy/role/NotesToFinancialStatementsOtherCurrentAssetsTextBlockTables Other Current Assets (Tables) R20.xml false false R21.htm 122 - Disclosure - Related Party Transactions (Tables) Sheet http://www.opexatherapeutics.com/taxonomy/role/NotesToFinancialStatementsRelatedPartyTransactionsDisclosureTextBlockTables Related Party Transactions (Tables) R21.xml false false R22.htm 123 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.opexatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlockTables Stock-Based Compensation (Tables) R22.xml false false R23.htm 124 - Disclosure - Significant Accounting Policies - Additional Information (Detail) Sheet http://www.opexatherapeutics.com/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformation Significant Accounting Policies - Additional Information (Detail) R23.xml false false R24.htm 125 - Disclosure - Other Current Assets (Detail) Sheet http://www.opexatherapeutics.com/taxonomy/role/DisclosureOtherCurrentAssets Other Current Assets (Detail) R24.xml false false R25.htm 126 - Disclosure - Other Current Assets - Additional Information (Detail) Sheet http://www.opexatherapeutics.com/taxonomy/role/DisclosureOtherCurrentAssetsAdditionalInformation Other Current Assets - Additional Information (Detail) R25.xml false false R26.htm 127 - Disclosure - Restricted Cash - Additional Information (Detail) Sheet http://www.opexatherapeutics.com/taxonomy/role/DisclosureRestrictedCashAdditionalInformation Restricted Cash - Additional Information (Detail) R26.xml false false R27.htm 128 - Disclosure - Deferred Financing Costs - Additional Information (Detail) Sheet http://www.opexatherapeutics.com/taxonomy/role/DisclosureDeferredFinancingCostsAdditionalInformation Deferred Financing Costs - Additional Information (Detail) R27.xml false false R28.htm 129 - Disclosure - Other Assets - Additional Information (Detail) Sheet http://www.opexatherapeutics.com/taxonomy/role/DisclosureOtherAssetsAdditionalInformation Other Assets - Additional Information (Detail) R28.xml false false R29.htm 130 - Disclosure - Convertible Promissory Notes - Additional Information (Detail) Notes http://www.opexatherapeutics.com/taxonomy/role/DisclosureConvertiblePromissoryNotesAdditionalInformation Convertible Promissory Notes - Additional Information (Detail) R29.xml false false R30.htm 131 - Disclosure - Summary of Changes in Convertible Debt Third Parties Net of Unamortized Discount (Detail) Sheet http://www.opexatherapeutics.com/taxonomy/role/DisclosureSummaryOfChangesInConvertibleDebtThirdPartiesNetOfUnamortizedDiscount Summary of Changes in Convertible Debt Third Parties Net of Unamortized Discount (Detail) R30.xml false false R31.htm 132 - Disclosure - Related Party Transactions - Additional Information (Detail) Sheet http://www.opexatherapeutics.com/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformation Related Party Transactions - Additional Information (Detail) R31.xml false false R32.htm 133 - Disclosure - Summary of Changes in Convertible Debt Related Parties Net of Unamortized Discount (Detail) Sheet http://www.opexatherapeutics.com/taxonomy/role/DisclosureSummaryOfChangesInConvertibleDebtRelatedPartiesNetOfUnamortizedDiscount Summary of Changes in Convertible Debt Related Parties Net of Unamortized Discount (Detail) R32.xml false false R33.htm 134 - Disclosure - Equity - Additional Information (Detail) Sheet http://www.opexatherapeutics.com/taxonomy/role/DisclosureEquityAdditionalInformation Equity - Additional Information (Detail) R33.xml false false R34.htm 135 - Disclosure - Stock-Based Compensation - Additional Information (Detail) Sheet http://www.opexatherapeutics.com/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformation Stock-Based Compensation - Additional Information (Detail) R34.xml false false R35.htm 136 - Disclosure - Stock Option Activity (Detail) Sheet http://www.opexatherapeutics.com/taxonomy/role/DisclosureStockOptionActivity Stock Option Activity (Detail) R35.xml false false R36.htm 137 - Disclosure - Warrant Activity (Detail) Sheet http://www.opexatherapeutics.com/taxonomy/role/DisclosureWarrantActivity Warrant Activity (Detail) R36.xml false false R37.htm 138 - Disclosure - Subsequent Event - Additional Information (Detail) Sheet http://www.opexatherapeutics.com/taxonomy/role/DisclosureSubsequentEventAdditionalInformation Subsequent Event - Additional Information (Detail) R37.xml false false All Reports Book All Reports Element us-gaap_ContractsRevenue had a mix of decimals attribute values: -6 0. 'Monetary' elements on report '134 - Disclosure - Equity - Additional Information (Detail)' had a mix of different decimal attribute values. 'Monetary' elements on report '138 - Disclosure - Subsequent Event - Additional Information (Detail)' had a mix of different decimal attribute values. Process Flow-Through: 103 - Statement - Consolidated Balance Sheets Process Flow-Through: Removing column 'Jun. 30, 2012' Process Flow-Through: Removing column 'Dec. 31, 2011' Process Flow-Through: 104 - Statement - Consolidated Balance Sheets (Parenthetical) Process Flow-Through: 105 - Statement - Consolidated Statements of Operations Process Flow-Through: 107 - Statement - Consolidated Statements of Changes In Stockholders' Equity (Parenthetical) Process Flow-Through: 108 - Statement - Consolidated Statements of Cash Flows opxa-20130630.xml opxa-20130630.xsd opxa-20130630_cal.xml opxa-20130630_def.xml opxa-20130630_lab.xml opxa-20130630_pre.xml true true